drugset / Trial / NCT00990028

Effect of Rosuvastatin on Cytokines After Traumatic Brain Injury

NCT00990028

RandomizedSingle-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether rosuvastatin could alter the immunological response after head injury by modulating TNF-alpha,IL6,IL-1.

Timeline

Start
2009-08
Primary completion
2011-07
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg Oral

Indications